These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28462209)

  • 1. Lung ischemia reperfusion injury: the therapeutic role of dipeptidyl peptidase 4 inhibition.
    Beckers PAJ; Gielis JF; Van Schil PE; Adriaensen D
    Ann Transl Med; 2017 Mar; 5(6):129. PubMed ID: 28462209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dipeptidyl peptidase 4 as a therapeutic target in ischemia/reperfusion injury.
    Matheeussen V; Jungraithmayr W; De Meester I
    Pharmacol Ther; 2012 Dec; 136(3):267-82. PubMed ID: 22850530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of dipeptidyl peptidase-IV enzyme activity protects against myocardial ischemia-reperfusion injury in rats.
    Chua S; Lee FY; Tsai TH; Sheu JJ; Leu S; Sun CK; Chen YL; Chang HW; Chai HT; Liu CF; Lu HI; Yip HK
    J Transl Med; 2014 Dec; 12():357. PubMed ID: 25496837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory effects on ischemia/reperfusion-injured lung transplants by the cluster of differentiation 26/dipeptidylpeptidase 4 (CD26/DPP4) inhibitor vildagliptin.
    Jang JH; Yamada Y; Janker F; De Meester I; Baerts L; Vliegen G; Inci I; Chatterjee S; Weder W; Jungraithmayr W
    J Thorac Cardiovasc Surg; 2017 Mar; 153(3):713-724.e4. PubMed ID: 27939504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of Prostanoids Profile and Counter-Regulation of SDF-1α/CXCR4 and VIP/VPAC2 Expression by Sitagliptin in Non-Diabetic Rat Model of Hepatic Ischemia-Reperfusion Injury.
    Krzystek-Korpacka M; Fleszar MG; Fortuna P; Gostomska-Pampuch K; Lewandowski Ł; Piasecki T; Kosyk B; Szeląg A; Trocha M
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DPP4 inhibition improves functional outcome after renal ischemia-reperfusion injury.
    Glorie LL; Verhulst A; Matheeussen V; Baerts L; Magielse J; Hermans N; D'Haese PC; De Meester I; De Beuf A
    Am J Physiol Renal Physiol; 2012 Sep; 303(5):F681-8. PubMed ID: 22718884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What doesn't kill you makes you stranger: Dipeptidyl peptidase-4 (CD26) proteolysis differentially modulates the activity of many peptide hormones and cytokines generating novel cryptic bioactive ligands.
    Elmansi AM; Awad ME; Eisa NH; Kondrikov D; Hussein KA; Aguilar-Pérez A; Herberg S; Periyasamy-Thandavan S; Fulzele S; Hamrick MW; McGee-Lawrence ME; Isales CM; Volkman BF; Hill WD
    Pharmacol Ther; 2019 Jun; 198():90-108. PubMed ID: 30759373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Potentials of the DPP-4 Inhibitor Sitagliptin against Ischemia-Reperfusion (I/R) Injury in Rat Ex-Vivo Heart Model.
    Al-Awar A; Almási N; Szabó R; Takacs I; Murlasits Z; Szűcs G; Török S; Pósa A; Varga C; Kupai K
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30340421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DPP-4 enzyme deficiency protects kidney from acute ischemia-reperfusion injury: role for remote intermittent bowel ischemia-reperfusion preconditioning.
    Chen YT; Wallace CG; Yang CC; Chen CH; Chen KH; Sung PH; Chen YL; Chai HT; Chung SY; Chua S; Lee FY; Ko SF; Lee MS; Yip HK
    Oncotarget; 2017 Aug; 8(33):54821-54837. PubMed ID: 28903385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular Sites and Mechanisms Linking Reduction of Dipeptidyl Peptidase-4 Activity to Control of Incretin Hormone Action and Glucose Homeostasis.
    Mulvihill EE; Varin EM; Gladanac B; Campbell JE; Ussher JR; Baggio LL; Yusta B; Ayala J; Burmeister MA; Matthews D; Bang KWA; Ayala JE; Drucker DJ
    Cell Metab; 2017 Jan; 25(1):152-165. PubMed ID: 27839908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dipeptidyl Peptidase-4 Regulates Hematopoietic Stem Cell Activation in Response to Chronic Stress.
    Zhu E; Hu L; Wu H; Piao L; Zhao G; Inoue A; Kim W; Yu C; Xu W; Bando YK; Li X; Lei Y; Hao CN; Takeshita K; Kim WS; Okumura K; Murohara T; Kuzuya M; Cheng XW
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28710180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraoxonase 2 protects against acute myocardial ischemia-reperfusion injury by modulating mitochondrial function and oxidative stress via the PI3K/Akt/GSK-3β RISK pathway.
    Sulaiman D; Li J; Devarajan A; Cunningham CM; Li M; Fishbein GA; Fogelman AM; Eghbali M; Reddy ST
    J Mol Cell Cardiol; 2019 Apr; 129():154-164. PubMed ID: 30802459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.
    Klemann C; Wagner L; Stephan M; von Hörsten S
    Clin Exp Immunol; 2016 Jul; 185(1):1-21. PubMed ID: 26919392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor γ (PPARγ) mediates the protective effect of quercetin against myocardial ischemia-reperfusion injury via suppressing the NF-κB pathway.
    Liu X; Yu Z; Huang X; Gao Y; Wang X; Gu J; Xue S
    Am J Transl Res; 2016; 8(12):5169-5186. PubMed ID: 28077993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of Dipeptidyl peptidase inhibitors in lung ischemia-reperfusion injury].
    Lu ZL; Gao ML; Deng Y; Liu BH; Li N; Geng Q
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Dec; 45(12):1266-1270. PubMed ID: 36480859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DUSP14 knockout accelerates cardiac ischemia reperfusion (IR) injury through activating NF-κB and MAPKs signaling pathways modulated by ROS generation.
    Lin B; Xu J; Feng DG; Wang F; Wang JX; Zhao H
    Biochem Biophys Res Commun; 2018 Jun; 501(1):24-32. PubMed ID: 29660332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dipeptidyl peptidase-4 modulates left ventricular dysfunction in chronic heart failure via angiogenesis-dependent and -independent actions.
    Shigeta T; Aoyama M; Bando YK; Monji A; Mitsui T; Takatsu M; Cheng XW; Okumura T; Hirashiki A; Nagata K; Murohara T
    Circulation; 2012 Oct; 126(15):1838-51. PubMed ID: 23035207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
    Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C
    Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-talk between the dipeptidyl peptidase-4 and stromal cell-derived factor-1 in stem cell homing and myocardial repair: Potential impact of dipeptidyl peptidase-4 inhibitors.
    Anderluh M; Kocic G; Tomovic K; Kocic R; Deljanin-Ilic M; Smelcerovic A
    Pharmacol Ther; 2016 Nov; 167():100-107. PubMed ID: 27484974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders.
    Kauppinen A; Suuronen T; Ojala J; Kaarniranta K; Salminen A
    Cell Signal; 2013 Oct; 25(10):1939-48. PubMed ID: 23770291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.